For cancers of the colon, rectum, gastric cardia, liver, gallbladder, pancreas, and kidney and for esophageal adenocarcinoma, significant associations between body mass index (BMI) and cancer risk were reported, with positive dose-response relationships. Relative risks from meta-analyses or pooled analyses were 1.2-1.5 for overweight (BMI 25.0-29.9) and 1.5-1.8 for obesity (BMI ≥ 30.0) with respect to cancers of the colon, gastric cardia, liver, gallbladder, pancreas, and kidney; the relative risk for esophageal adenocarcinoma was up to 4.8 for a BMI of ≥ 40.
No comments:
Post a Comment